NUCKS1

NUCKS1 is a vertebrate-specific, heavily post-translationally modified nuclear chromatin-associated protein that functions both as a transcriptional activator and as a direct regulator of homologous recombination DNA repair. As a transcription factor, NUCKS1 binds gene promoters via an alpha-helical DNA-binding domain—whose activity is abolished by CDK1-mediated phosphorylation during mitosis—and drives expression of diverse targets including the insulin receptor, SKP2, ASNS, Cdc42, and CXCL8, thereby controlling insulin/metabolic signaling, the G1/S cell cycle checkpoint (via the NUCKS1–SKP2–p21/p27 axis), and cell proliferation (PMID:12413487, PMID:24931609, PMID:34845229, PMID:37528150, PMID:40226459). In the DNA damage response, NUCKS1 is phosphorylated by ATM and DNA-PK, physically interacts with RAD54 to stimulate its ATPase activity, and promotes RAD51–RAD54-mediated strand invasion during homologous recombination, with its depletion causing increased sensitivity to DNA crosslinking agents and chromosomal instability (PMID:28011258, PMID:26323318, PMID:32876692). NUCKS1 undergoes cell-cycle-dependent phosphorylation by CDK1 and CK2, acetylation, and methylation, and enters the nucleus through importin alpha3/alpha5-mediated import via two NLS sequences (PMID:11298763, PMID:18491381, PMID:17604136).

1. 2001 High

   Establishing that NUCKS1 is a cell-cycle-regulated CDK1 substrate resolved the question of how this nuclear protein is modified during mitosis and suggested a functional connection to cell division.

   Evidence Phosphopeptide mapping and back-phosphorylation of endogenous NUCKS1 from synchronized HeLa cells

   PMID:11298763

   Open questions at the time

   • Functional consequence of CDK1 phosphorylation was unknown
   • Other kinases phosphorylating NUCKS1 had not been tested
   • No connection to a specific cellular process established
2. 2002 High

   Determining that NUCKS1 possesses an alpha-helical DNA-binding domain whose activity is abolished by CDK1 phosphorylation provided the first mechanistic link between mitotic phosphorylation and a molecular function—DNA binding is switched off during cell division.

   Evidence NMR structure of synthetic DNA-binding peptide, molecular docking, and in vitro phosphorylation coupled with DNA binding assay

   PMID:12413487

   Open questions at the time

   • Genomic targets of DNA binding were unknown
   • In vivo DNA-binding regulation by CDK1 not demonstrated
   • Whether NUCKS1 acts as a transcription factor was unresolved
3. 2004 Medium

   Demonstrating that the DNA-binding domain and CDK1/CK2 phosphorylation sites are conserved across vertebrates established NUCKS1 as a vertebrate-specific, multiply-phosphorylated chromatin protein with conserved regulation.

   Evidence In vitro kinase assays on fish ortholog with CDK1 and CK2, sequence conservation analysis

   PMID:15381070

   Open questions at the time

   • In vivo CK2 phosphorylation sites not mapped
   • Functional significance of CK2 phosphorylation unknown
   • Single-lab in vitro study
4. 2007 High

   Identifying two NLS sequences and showing that nuclear import depends on importin alpha3/alpha5 resolved how NUCKS1 reaches chromatin and explained the mechanism underlying its constitutive nuclear localization.

   Evidence GFP-fusion translocation assays, site-directed mutagenesis of NLS motifs, GST pulldown with importin alpha isoforms

   PMID:17604136

   Open questions at the time

   • Whether nuclear import is regulated during the cell cycle was not tested
   • Relative contribution of importin alpha3 vs alpha5 in vivo unclear
5. 2008 High

   Comprehensive SILAC-based quantitative proteomics revealed at least 25 phosphorylation sites plus acetylation, methylation, and formylation, with cell-cycle-dependent dynamics—establishing NUCKS1 as one of the most heavily modified nuclear proteins and suggesting multiple regulatory inputs.

   Evidence SILAC mass spectrometry of NUCKS1 from asynchronous, mitotically arrested, and G1-arrested HeLa cells

   PMID:18491381

   Open questions at the time

   • Functional roles of individual PTM sites were mostly unknown
   • Enzymes responsible for acetylation, methylation, and formylation not identified
6. 2014 High

   ChIP-seq and knockout mouse studies established NUCKS1 as a bona fide transcription factor that binds gene promoters genome-wide, with its transcriptional activation of the insulin receptor linking it directly to metabolic regulation—knockout mice exhibit glucose intolerance and insulin resistance.

   Evidence Genome-wide ChIP-seq, NUCKS1 global knockout mice, glucose and insulin tolerance tests, knockdown in endocrine cells

   PMID:24931609

   Open questions at the time

   • DNA sequence motif for NUCKS1 binding not fully defined
   • Mechanism by which NUCKS1 activates transcription at promoters unknown
   • Whether metabolic phenotype is cell-autonomous or systemic was unclear
7. 2015 High

   Tissue-specific knockout showed the metabolic phenotype is driven by hypothalamic NUCKS1, resolving the question of tissue autonomy—NUCKS1 in the brain regulates peripheral glucose homeostasis through control of central insulin receptor levels.

   Evidence Hypothalamus-specific conditional knockout (Nkx2.1-Cre), intracerebroventricular insulin, glucose tolerance tests; immune-cell-specific deletion served as negative control

   PMID:26205492

   Open questions at the time

   • Downstream hypothalamic signaling cascade not fully elucidated
   • Whether NUCKS1 has additional peripheral metabolic functions not excluded
8. 2015 High

   Demonstrating that NUCKS1 depletion impairs homologous recombination, causes chromosomal breaks, sensitizes cells to DNA crosslinkers, and slows replication forks established a second major function for NUCKS1 in genome maintenance, paralleling its paralog RAD51AP1.

   Evidence HR reporter assay, DNA fiber analysis, mitomycin C sensitivity, chromosomal break scoring, in vitro DNA binding with recombinant NUCKS1

   PMID:26323318

   Open questions at the time

   • Direct protein partners in HR pathway not yet identified
   • Whether NUCKS1 and RAD51AP1 are redundant or have distinct roles was unresolved
9. 2016 High

   Mapping 11 CK2 and 2 ATM/DNA-PK phosphorylation sites—with in vivo confirmation that ATM phosphorylates NUCKS1 after gamma irradiation—connected the extensive PTM landscape to the DNA damage response kinase cascade.

   Evidence In vitro kinase assays with CK2, ATM, DNA-PK; in vivo phosphorylation with kinase inhibitors; mass spectrometry and phosphospecific antibodies

   PMID:28011258

   Open questions at the time

   • Functional consequence of individual ATM/DNA-PK phosphosites not determined
   • Whether phosphorylation regulates NUCKS1 HR activity not tested
10. 2020 High

    Biochemical reconstitution showed NUCKS1 directly stimulates RAD54 ATPase activity and promotes RAD51–RAD54-mediated D-loop formation, resolving the mechanistic basis of NUCKS1's role in homologous recombination—it acts as a direct activator of the strand invasion machinery and prevents aberrant RAD54–RAD51AP1 engagement in unperturbed cells.

    Evidence Co-immunoprecipitation of NUCKS1–RAD54, in vitro ATPase and D-loop assays with purified proteins, immunofluorescence foci analysis

    PMID:32876692

    Open questions at the time

    • Structural basis of NUCKS1–RAD54 interaction unknown
    • How ATM/DNA-PK phosphorylation regulates this interaction not tested
    • Whether NUCKS1 acts at replication-associated vs DSB-associated HR not distinguished
11. 2021 High

    Identifying the NUCKS1–SKP2–p21/p27 checkpoint axis showed how NUCKS1's transcriptional activity integrates mitogenic and DNA damage signals to control the G1/S transition—NUCKS1 activates SKP2 transcription for S-phase entry, and p53 represses NUCKS1 after DNA damage to enforce cell cycle arrest.

    Evidence ChIP for NUCKS1 at SKP2 promoter, epistasis experiments with siRNA/shRNA, luciferase reporter, cell cycle analysis

    PMID:34845229

    Open questions at the time

    • Whether p53 directly binds the NUCKS1 promoter or acts indirectly not resolved
    • How NUCKS1 transcriptional and HR functions are coordinated temporally is unknown
12. 2023 Medium

    Expanding the repertoire of NUCKS1 transcriptional targets to include ASNS, Cdc42, CXCL8, and S100A9 across multiple cancer types demonstrated that NUCKS1 functions as a versatile transcriptional activator of proliferative and metabolic gene programs.

    Evidence ChIP and luciferase reporter assays for NUCKS1 binding at ASNS, Cdc42, CXCL8, and S100A9 promoters in osteosarcoma, HCC, CRC, and HNSCC models

    PMID:37528150 PMID:38636892 PMID:40226459 PMID:40946978

    Open questions at the time

    • DNA binding motif for NUCKS1 across these promoters not defined
    • Most targets validated in single-lab studies in cancer contexts
    • Whether these targets are direct in normal physiology is unclear

• Key open questions include the structural basis of NUCKS1–RAD54 interaction, the precise DNA sequence motif recognized by NUCKS1 as a transcription factor, how ATM/DNA-PK phosphorylation regulates NUCKS1's HR versus transcriptional functions, and whether the transcriptional and HR activities of NUCKS1 are coordinated or independently regulated during the cell cycle.
• No structural model of full-length NUCKS1 or its complexes
• Consensus DNA binding motif not defined
• Functional significance of most individual PTM sites remains untested